Buying Time: The AMR Action Fund and the State of Antibiotic Development in the United States 2020

Antimicrobial resistance is a pressing global threat, but companies developing antibiotics are failing. Large pharmaceutical companies recently created the AMR Action Fund, which will invest $1 billion in small antibiotic development companies. To understand the state of antibiotic development in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Clancy, Cornelius J, Nguyen, M Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652093/
https://www.ncbi.nlm.nih.gov/pubmed/33209952
http://dx.doi.org/10.1093/ofid/ofaa464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652093/
https://www.ncbi.nlm.nih.gov/pubmed/33209952
http://dx.doi.org/10.1093/ofid/ofaa464

Ejemplares similares